Danny Soon
Danny is currently the Senior Director at the Biomedical Research Council (BMRC), he joined A*STAR in 2015.
He previously worked at Eli Lilly and Company for 15 years in early phase clinical development, where he headed up the Lilly-NUS Centre for Clinical Pharmacology (LNUS).
As the Managing Director and Principal Investigator, Danny had responsibility and oversight for all clinical Phase 1 studies conducted and operations in the unit.
As an investigator, Danny was personally involved in over 90 clinical pharmacology studies, and oversaw over 130 studies at Lilly-NUS in various roles. This includes first-in-human studies, biomarker development work, human physiology investigations and pivotal registration PK studies, in neuroscience, diabetes, musculoskeletal and cardiovascular therapeutic areas.
He previously worked at Eli Lilly and Company for 15 years in early phase clinical development, where he headed up the Lilly-NUS Centre for Clinical Pharmacology (LNUS).
As the Managing Director and Principal Investigator, Danny had responsibility and oversight for all clinical Phase 1 studies conducted and operations in the unit.
As an investigator, Danny was personally involved in over 90 clinical pharmacology studies, and oversaw over 130 studies at Lilly-NUS in various roles. This includes first-in-human studies, biomarker development work, human physiology investigations and pivotal registration PK studies, in neuroscience, diabetes, musculoskeletal and cardiovascular therapeutic areas.
Country:
Singapore